Cosmetic Compound

Eyeliss

Cosmetic blend (hesperidin methyl chalcone + dipeptide-2 + pal-tetrapeptide-7) for under-eye bags.

Scientific Overview

Eyeliss is a Sederma-formulated blend of hesperidin methyl chalcone, dipeptide-2 (VW), and palmitoyl tetrapeptide-7. Manufacturer-sponsored studies report reduced under-eye puffiness over 8 weeks via lymphatic drainage and mild anti-inflammatory effects. Like most cosmetic peptide blends, independent confirmation is limited but the safety profile is benign.

Key Research Benefits

  • Reduces puffy under-eyes
  • Improves microcirculation
  • Decreases dermal inflammation

Potential Side Effects

Localized irritation (rare)

Research Protocols

Common Dosages

Topical

1-3%
Daily AM/PM

Eye area

Note: Dosages listed are common research protocols found in peer-reviewed literature and clinical trials. Individual results and requirements may vary significantly in a research context.

Dose Calculator

🧮 Peptide Reconstitution Calculator

mg

Total amount of peptide in the vial.

mL

Volume of water used to mix.

mcg

Draw to this mark

10 Units

or 0.10 mL on a U-100 syringe

Concentration:2.50 mg/mL
Peptide per Unit:25.00 mcg/unit
*Always double-check your calculations. This tool is for educational purposes only.

Explore Eyeliss

Where to source

Vendors with public COAs that stock this category. Affiliate links are disclosed.

  • Limitless Life Nootropics
    FL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.
    COA: JanoshikAffiliate disclosed
  • SwissChems
    60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.
    COA: JanoshikAffiliate disclosed
  • Amino Club
    EU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.
    COA: Third-partyAffiliate disclosed

Eyeliss by goal

Read Eyeliss's profile filtered through specific research goals.

Molecular Profile

linear
blend (dipeptide-2 + pal-tetrapeptide-7)
2 AA Sequence

Quick Reference

Status
Research Compound
Category
Cosmetic
Common Dosage
1-3%
Daily AM/PM

Strictly for research purposes. Not for human consumption.

Medical Disclaimer

Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.